Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Oncoplastic Surgery Outcomes Database
for
Breast Cancer
Location: Boston MA
Sponsor: Tufts Medical Center
Sex: Female
Age: 18+
Code: NCT07597837
Recruiting
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
for
Craniopharyngioma, Child, Craniopharyngioma,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Sabine Mueller, MD, PhD
Sex: All
Age: 1 - 39
Code: NCT05465174
Phase 2, Recruiting
Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults
for
Binge Alcohol Consumption, Suicidal Ideation
Location: Marlborough MA, Worcester MA
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 18 - 29
Code: NCT07418047
Recruiting
A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder
for
Borderline Personality Disorder (BPD)
Location: Belmont MA
Sponsor: Mclean Hospital
Sex: All
Age: 18+
Code: NCT07460947
Phase 1, Phase 2, Recruiting
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
for
Diffuse Intrinsic Pontine Glioma,
Location: Boston MA, Chicago IL, Orange CA
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Sex: All
Age: 1 - 18
Code: NCT04943848
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Boston MA, Washington D.C. DC, Bethesda MD, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma